Myeloid-derived suppressor cells exert immunosuppressive function on the T helper 2 in mice infected with Echinococcus granulosus

被引:4
|
作者
Zhou, Xiaojing [3 ,6 ]
Wang, Wen [1 ]
Cui, Fang [1 ]
Shi, Chunli [1 ]
Gao, Xiaoping [5 ]
Ouyang, Jiaxin [1 ]
Wang, Yuxin [3 ]
Nagai, Atsushi [6 ]
Zhao, Wei [1 ,2 ]
Yin, Mei [4 ]
Zhao, Jiaqing [1 ,2 ]
机构
[1] Ningxia Med Univ, Sch Basic Med Sci, Yinchuan 750004, Ningxia, Peoples R China
[2] Ningxia Med Univ, Ctr Sci Technol, Yinchuan 750004, Ningxia, Peoples R China
[3] Ningxia Med Univ, Coll Clin Med, Yinchuan 750004, Ningxia, Peoples R China
[4] Ningxia Med Univ, Cardiovasc Hosp Cardiovasc Hosp, Gen Hosp, Yinchuan 750004, Ningxia, Peoples R China
[5] Ningxia Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Gen Hosp, Yinchuan 750004, Ningxia, Peoples R China
[6] Shimane Univ, Dept Neurol, Fac Med, Izumo, Shimane 6938501, Japan
基金
中国国家自然科学基金;
关键词
Echinococcus granulosus; Myeloid-derived suppressor cells (MDSCs); Immunosuppressive function; CYSTIC ECHINOCOCCOSIS; RESPONSES; CYTOKINE; BALANCE;
D O I
10.1016/j.exppara.2020.107917
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Cystic echinococcosis (CE) is a worldwide hazardous zoonotic parasitosis caused by Echinococcus granulosus. CE development involves complex immunological mechanisms, including participation of multiple immune cells and effector molecules. Myeloid-derived suppressor cells (MDSCs) are known to be involved in chronic and acute inflammatory conditions. In this study, we aimed to characterize the immune function of MDSCs in CE to improve the understanding, prevention and treatment of CE. Our results indicated that MDSCs overexpressing Ly6C and Ly6G inhibit the formation and activity of T helper 2 cells in a NO-dependent manner during E. granulosus infection.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Cyclosporine enhances immunosuppressive functions of myeloid-derived suppressor cells in immune thrombocytopenia
    Hou, Y.
    Xu, M.
    Feng, Q.
    Yu, Y.
    Liu, X.
    Hou, M.
    Peng, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 26 - 26
  • [42] Immunosuppressive myeloid-derived suppressor cells are increased in splenocytes from cancer patients
    Jordan, Kimberly R.
    Kapoor, Puja
    Spongberg, Eric
    Tobin, Richard P.
    Gao, Dexiang
    Borges, Virginia F.
    McCarter, Martin D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (04) : 503 - 513
  • [43] Myeloid-derived suppressor cells: Key immunosuppressive regulators and therapeutic targets in cancer
    Li, Lingfei
    Li, Mingyang
    Jia, Qingge
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [44] Immunosuppressive Role of Myeloid-Derived Suppressor Cells and Therapeutic Targeting in Lung Cancer
    Ma, Jie
    Xu, Huaxi
    Wang, Shengjun
    JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
  • [45] Regulation of suppressive function of myeloid-derived suppressor cells by CD4+ T cells
    Nagaraj, Srinivas
    Gabrilovich, Dmitry I.
    SEMINARS IN CANCER BIOLOGY, 2012, 22 (04) : 282 - 288
  • [46] Modulation of T-cell function by myeloid-derived suppressor cells in hematological malignancies
    Bhardwaj, Vaishali
    Ansell, Stephen M. M.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [47] Function of reactive oxygen species in myeloid-derived suppressor cells
    Huang, Jiaojiao
    Zhao, Yue
    Zhao, Kexin
    Yin, Kai
    Wang, Shengjun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] VISTA REGULATES THE DIFFERENTIATION AND FUNCTION OF MYELOID-DERIVED SUPPRESSOR CELLS
    Zhang, Keman
    Zekeri, Amin
    Dong, Juan
    Stone, Sarah
    Wang, Li
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A1013 - A1013
  • [49] Epigenetic modifications in the accumulation and function of myeloid-derived suppressor cells
    Xu, Liangjie
    Zhou, Cuicui
    Liang, Yi
    Fan, Tinpan
    Zhang, Fen
    Chen, Xinxin
    Yuan, Wei
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [50] Phenotype, development, and biological function of myeloid-derived suppressor cells
    Zhao, Yang
    Wu, Tingting
    Shao, Steven
    Shi, Bingyi
    Zhao, Yong
    ONCOIMMUNOLOGY, 2016, 5 (02):